Mecasermin, also known as recombinant human insulin-like growth factor-1 (rhIGF-1), is a recombinant form of human insulin-like growth factor 1 (IGF-I) which is used in the long-term treatment of growth failure and short stature in children with severe primary IGF-I deficiency, for instance due to growth hormone deficiency or Laron syndrome (growth hormone insensitivity).
CAT No: 10-101-335
CAS No: 68562-41-4
Synonyms/Alias: FK-780; Recombinant human insulin-like growth factor-1; rhIGF-1; Somatomedin-1
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C331H512N94O101S7 |
M.W/Mr. | 7648.71 |
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.